Skip to content
Video screenshot

Video: Examining excimer laser technology from Elios Vision with Ike Ahmed

Originally published in The Ophthalmologist October 2022

The development and widespread adoption of MIGS has had a seismic impact on the way we treat glaucoma over the past two decades. This is especially true for patients who do not need intense surgical intervention, but who find that drops alone do not sufficiently address IOP because of issues around adherence or efficacy. In this video, Ike Ahmed, one of the world’s leading glaucoma specialists, joins The Ophthalmologist team to discuss the ELIOS procedure. Using an excimer laser device allows the creation of microscoping openings in the trabecular meshwork in a way that creates less inflammation and has few surgical downsides. The ELIOS procedure is an important tool for interventional glaucoma treatment and offers another option to treat symptoms early and maintain the best possible outcomes for patients.

Share This Story

Latest News

Elios Vision announces collaboration with the International Glaucoma Surgical Registry

Elios Vision will be collaborating with the ISGR, an open-access tool which enables surgeons to compare outcomes with other centres.
Elios Vision logo

Elios Vision achieves three new pipeline milestones

Elios announced enrollment completion in their U.S. pivotal trial, the expansion of the U.S. pre-launch team, and continued commercial uptake in Europe.
The Ophthalmologist logo

The ELegance of ELIOS

Learn why Dusseldorf-based surgeon Karsten Klabe prefers the ELIOS procedure when treating patients for open-angle glaucoma.

Join Our Email List

Stay up-to-date on the next generation of glaucoma treatment. Subscribe to receive educational and promotional information from Elios Vision.

Email Signup

Site for Healthcare Professionals Only

You are about to access Elios Vision’s online platform for healthcare professionals outside of the United States. This platform is intended to provide general product information for education and illustration purposes. It is not intended to provide information to the general public or medical advice.

As product information, availability, indication, and trade names may vary from country to country, the content of this site may not be fully in-line with the approved or cleared product information in the country you are accessing from. Unless stated otherwise for specific product or event pages, the content on this site is based on the regulatory and legal principles applicable to the United Kingdom.

By clicking “Proceed,” I confirm that:

  • I understand that this platform is directed to Healthcare Professionals only and that I am a licensed Healthcare Professional.
  • I have read and agree to Elios Vision’s terms and conditions and privacy policy.